These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27869670)

  • 1. Homologous Prime-Boost Vaccination with OVA Entrapped in Self-Adjuvanting Archaeosomes Induces High Numbers of OVA-Specific CD8⁺ T Cells that Protect Against Subcutaneous B16-OVA Melanoma.
    Stark FC; McCluskie MJ; Krishnan L
    Vaccines (Basel); 2016 Nov; 4(4):. PubMed ID: 27869670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid clonal expansion and prolonged maintenance of memory CD8+ T cells of the effector (CD44highCD62Llow) and central (CD44highCD62Lhigh) phenotype by an archaeosome adjuvant independent of TLR2.
    Krishnan L; Gurnani K; Dicaire CJ; van Faassen H; Zafer A; Kirschning CJ; Sad S; Sprott GD
    J Immunol; 2007 Feb; 178(4):2396-406. PubMed ID: 17277146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
    Krishnan L; Sad S; Patel GB; Sprott GD
    J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Archaeosomes as self-adjuvanting delivery systems for cancer vaccines.
    Krishnan L; Dennis Sprott G;
    J Drug Target; 2003; 11(8-10):515-24. PubMed ID: 15203920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge.
    Krishnan L; Sad S; Patel GB; Sprott GD
    Cancer Res; 2003 May; 63(10):2526-34. PubMed ID: 12750276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Archaeosome-Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Significantly Enhances Protection from Murine Melanoma.
    Stark FC; Weeratna RD; Deschatelets L; Gurnani K; Dudani R; McCluskie MJ; Krishnan L
    Vaccines (Basel); 2017 Oct; 5(4):. PubMed ID: 29072624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Archaeosome adjuvant overcomes tolerance to tumor-associated melanoma antigens inducing protective CD8 T cell responses.
    Krishnan L; Deschatelets L; Stark FC; Gurnani K; Sprott GD
    Clin Dev Immunol; 2010; 2010():578432. PubMed ID: 21318177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylserine receptor-mediated recognition of archaeosome adjuvant promotes endocytosis and MHC class I cross-presentation of the entrapped antigen by phagosome-to-cytosol transport and classical processing.
    Gurnani K; Kennedy J; Sad S; Sprott GD; Krishnan L
    J Immunol; 2004 Jul; 173(1):566-78. PubMed ID: 15210818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular bacterial vectors that induce CD8(+) T cells with similar cytolytic abilities but disparate memory phenotypes provide contrasting tumor protection.
    Stark FC; Sad S; Krishnan L
    Cancer Res; 2009 May; 69(10):4327-34. PubMed ID: 19435919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of archaeosome adjuvants evaluated in a mouse model.
    Patel GB; Omri A; Deschatelets L; Sprott GD
    J Liposome Res; 2002 Nov; 12(4):353-72. PubMed ID: 12519630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and biodistribution of sulfated archaeal glycolipid archaeosomes as vaccine adjuvants.
    Akache B; Stark FC; Iqbal U; Chen W; Jia Y; Krishnan L; McCluskie MJ
    Hum Vaccin Immunother; 2018 Jul; 14(7):1746-1759. PubMed ID: 29336668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity.
    McCluskie MJ; Deschatelets L; Krishnan L
    Hum Vaccin Immunother; 2017 Dec; 13(12):2772-2779. PubMed ID: 28537465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma.
    Stark FC; Agbayani G; Sandhu JK; Akache B; McPherson C; Deschatelets L; Dudani R; Hewitt M; Jia Y; Krishnan L; McCluskie MJ
    Biomedicines; 2019 Nov; 7(4):. PubMed ID: 31771150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8(+) T cells specific to a single Yersinia pseudotuberculosis epitope restrict bacterial replication in the liver but fail to provide sterilizing immunity.
    Shen H; Gonzalez-Juarbe N; Blanchette K; Crimmins G; Bergman MA; Isberg RR; Orihuela CJ; Dube PH
    Infect Genet Evol; 2016 Sep; 43():289-96. PubMed ID: 27268148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methanobrevibacter smithii archaeosomes-entrapped mzNL4-3 virus-like particles induce specific T helper 1-oriented cellular and humoral responses against HIV-1.
    Salmani AS; Aghasadeghi MR; Nategh R; Mokhtari-Azad T; Siadat SD
    Curr HIV Res; 2013 Sep; 11(6):491-7. PubMed ID: 24329177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations.
    Agbayani G; Jia Y; Akache B; Chandan V; Iqbal U; Stark FC; Deschatelets L; Lam E; Hemraz UD; Régnier S; Krishnan L; McCluskie MJ
    Hum Vaccin Immunother; 2020 Sep; 16(9):2183-2195. PubMed ID: 32755430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8
    Kanuma T; Yamamoto T; Kobiyama K; Moriishi E; Masuta Y; Kusakabe T; Ozasa K; Kuroda E; Jounai N; Ishii KJ
    J Immunol; 2017 Jun; 198(12):4707-4715. PubMed ID: 28507029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Treg suppression by a listeriolysin-O-expressing E. coli vaccine in heterologous prime-boost vaccination against cancer.
    Dai MS; Vassaux G; Xu M; You RI; Hsieh YF; Ouisse LH; Lo KY; Sytwu HK; Chao TY
    Vaccine; 2012 Nov; 30(48):6903-11. PubMed ID: 22982404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8
    Ring SS; Królik M; Hartmann F; Schmidt E; Ali OH; Ludewig B; Kochanek S; Flatz L
    Mol Ther Oncolytics; 2020 Dec; 19():179-187. PubMed ID: 33209978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Archaeosome adjuvants: immunological capabilities and mechanism(s) of action.
    Krishnan L; Sprott GD
    Vaccine; 2008 Apr; 26(17):2043-55. PubMed ID: 18343538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.